 |
 |

Identification of Patients at Low Risk for Recurrent Venous Thromboembolism by Measuring Thrombin Generation
Gregor Hron, MD;
Marietta Kollars;
Bernd R. Binder, MD;
Sabine Eichinger, MD;
Paul A. Kyrle, MD
JAMA. 2006;296:397-402.
Context Screening of patients with venous thromboembolism (VTE) for thrombophilic risk factors is common clinical practice. Because of the large number of risk factors, assessing the risk of recurrence in an individual patient is complex. A method covering multicausal thrombophilia is therefore required.
Objective To investigate the relationship between recurrence of VTE and a simple global coagulation assay measuring thrombin generation.
Design, Setting, and Participants Prospective cohort study of 914 patients with first spontaneous VTE who were followed up for an average of 47 months after discontinuation of vitamin K antagonist therapy. The study was conducted at the Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria, between July 1992 and July 2005. Thrombin generation was measured by a commercially available assay system. Patients with a previous or secondary VTE; antithrombin, protein C, or protein S deficiencies; presence of lupus anticoagulant; cancer; or pregnancy were excluded.
Main Outcome Measure Objectively documented symptomatic recurrent VTE.
Results Venous thromboembolism recurred in 100 patients (11%). Patients without recurrent VTE had lower thrombin generation than patients with recurrence (mean [SD], 349.2 [108.0] nM vs 419.5 [110.5] nM, respectively; P<.001). Compared with patients who had thrombin generation greater than 400 nM, the relative risk (RR) of recurrence was 0.42 (95% confidence interval [CI], 0.26-0.67; P<.001) in patients with values between 400 nM and 300 nM; for patients with lower values, the RR was 0.37 (95% CI, 0.21-0.66; P = .001). After 4 years, the probability of recurrence was 6.5% (95% CI, 4.0%-8.9%) among patients with thrombin generation less than 400 nM compared with 20.0% (95% CI, 14.9%-25.1%) among patients with higher values (P<.001). Patients with thrombin generation less than 400 nM, representing two thirds of patients, had a 60% lower RR of recurrence than those with greater values (RR, 0.40; 95% CI, 0.27-0.60; P<.001).
Conclusion Measurement of thrombin generation identifies patients at low risk for recurrent VTE.
Author Affiliations: Departments of Internal Medicine I (Drs Hron, Eichinger, and Kyrle and Ms Kollars) and Vascular Biology and Thrombosis Research, Center for Biomolecular Medicine and Pharmacology (Dr Binder), Medical University of Vienna, Austria.
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
RELATED ARTICLE
Thrombophlebitis
Janet M. Torpy, Alison E. Burke, and Richard M. Glass
JAMA. 2006;296(4):468.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake
Lopez-Vilchez et al.
Cardiovasc Res 2009;0:cvp205v2-cvp205.
ABSTRACT
| FULL TEXT
Venous Thromboembolism: Risk Factors for Recurrence
Zhu et al.
Arterioscler. Thromb. Vasc. Bio. 2009;29:298-310.
ABSTRACT
| FULL TEXT
Biomarkers and Venous Thromboembolism
Pabinger and Ay
Arterioscler. Thromb. Vasc. Bio. 2009;29:332-336.
ABSTRACT
| FULL TEXT
Monitoring Thrombin Generation by Electrochemistry: Development of an Amperometric Biosensor Screening Test for Plasma and Whole Blood
Thuerlemann et al.
Clin. Chem. 2009;55:505-512.
ABSTRACT
| FULL TEXT
Prediction of Recurrent Venous Thromboembolism by Endogenous Thrombin Potential and D-Dimer
Eichinger et al.
Clin. Chem. 2008;54:2042-2048.
ABSTRACT
| FULL TEXT
The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis
Buyue et al.
Blood 2008;112:3234-3241.
ABSTRACT
| FULL TEXT
Thrombin-generating capacity in patients with von Willebrand's disease
Rugeri et al.
haematol 2007;92:1639-1646.
ABSTRACT
| FULL TEXT
Update in Hematology
DeLoughery
ANN INTERN MED 2007;147:717-724.
FULL TEXT
Risk of recurrence after a first venous thromboembolic event in young women
Laczkovics et al.
haematol 2007;92:1201-1207.
ABSTRACT
| FULL TEXT
Sophia
Cattermole and Wyatt
Emerg. Med. J. 2006;23:890-890.
FULL TEXT
What's new in the other general journals.
Tonks
BMJ 2006;333:295-296.
FULL TEXT
New Approach to Identifying VTE Patients at Risk for Recurrence
JWatch General 2006;2006:1-1.
FULL TEXT
|